Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of Dexmedetomidine as an Additive to Ropivacaine for Interscalene Brachial Plexus Blocks for Shoulder Surgery

NCT01557270 is registered in ClinicalTrials.gov with Prof. Peter Gerner, M.D. as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01557270 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of Dexmedetomidine as an Additive to Ropivacaine for Interscalene Brachial Plexus Blocks for Shoulder Surgery
Lead sponsor
Prof. Peter Gerner, M.D.
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2012
Completion date
November 30, 2012
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug safety, self efficacy